×
For best experience we recommend to activate Javascript in your browser.
PLAUR antibody (AA 13-114)
The Mouse Monoclonal anti-PLAUR antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect PLAUR in samples from Human.
Quick Overview for PLAUR antibody (AA 13-114) (ABIN7624814)
Target
See all PLAUR Antibodies
PLAUR
(Plasminogen Activator, Urokinase Receptor (PLAUR))
Reactivity
All reactivities for PLAUR antibodies
Human
Host
All hosts for PLAUR antibodies
Mouse
Clonality
All clonalities for PLAUR antibodies
Monoclonal
Conjugate
All conjugates for PLAUR antibodies
This PLAUR antibody is un-conjugated
Application
All applications for PLAUR antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Clone
D4
Product Details anti-PLAUR Antibody
(hide)
Binding Specificity
All epitopes for PLAUR antibodies
AA 13-114
Purpose
Plasminogen Activator, Urokinase Receptor (uPAR) Monoclonal Antibody
Sequence
Leu13~Tyr114
Characteristics
The Plasminogen Activator, Urokinase Receptor (uPAR) Monoclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Protein A + Protein G affinity chromatography
Isotype
IgG2a kappa
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for PLAUR
(hide)
Target
PLAUR
(Plasminogen Activator, Urokinase Receptor (PLAUR))
Alternative Name
uPAR
Gene ID
5329
UniProt
Q03405
Pathways
Inositol Metabolic Process
Recently viewed
(hide)
Chat with us , powered by LiveChat